Quick Answer
Sotera Health Co reported Cash And Cash Equivalents At Carrying Value of $344.62 million for the year ending 2025.
- Sotera Health Co showed an increase of +24.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Sotera Health Co's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $108.01 million | Q2 2021: $156.22 million | Q3 2021: $114.91 million | Q1 2022: $121.44 million | Q2 2022: $139.56 million | Q3 2022: $163.98 million | Q1 2023: $647.95 million | Q2 2023: $262.70 million | Q3 2023: $244.96 million | Q1 2024: $261.13 million | Q2 2024: $246.08 million | Q3 2024: $306.74 million | Q1 2025: $304.39 million | Q2 2025: $332.44 million | Q3 2025: $299.19 million.
- Over the full 6 years of available data (2020 to 2025), Sotera Health Co's Cash And Cash Equivalents At Carrying Value has grown by 236.4%.
- Historical annual values: Fiscal year 2025: $344.62 million | Fiscal year 2024: $277.24 million | Fiscal year 2023: $296.41 million | Fiscal year 2022: $395.21 million | Fiscal year 2021: $106.92 million | Fiscal year 2020: $102.45 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: